Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sanofi SA (SNY) vs Union Pacific Corporation (UNP) Price & Performance

Sanofi SATrade
Union Pacific CorporationTrade

Price performance (Past 24H)

Key statistics

Sanofi SA vs Union Pacific Corporation — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Union Pacific Corporation trades at $295.68 (market cap $175.89B). The key difference: Union Pacific Corporation is the larger of the two by market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.

SNYUNP
Market Cap
$104.83B$175.89B
Sector
HealthIndustrials
52-Week High
$52.34$301.75
52-Week Low
$41.33$214.91
Enterprise Value
$121.32B$206.36B
Dividend Yield
5.5%1.86%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY

About Union Pacific Corporation

Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.

Read more on UNP